Figure 1.
Landmark studies showing the effectiveness of renin–angiotensin system inhibitors on diabetic kidney disease, and cardiovascular mortality and morbidity.
Landmark studies showing the effectiveness of renin–angiotensin system inhibitors on diabetic kidney disease, and cardiovascular mortality and morbidity.